Phrixus Pharma Wins NIH Grants
Phrixus Pharmaceuticals of Ann Arbor, MI has won $890,000 in grants from the National Institutes of Health. The University of Michigan spinoff is developing drugs to treat muscular dystrophy and heart failure.
CEO and Founder, Techstars
Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
Founder and Managing Partner, Frazier Healthcare Ventures